P4 peptide may lead to antibody induction, and such antibodies could theoretically engage FcγR-expressing effector cells (e.g., NK cells, macrophages) to eliminate tumor cells via ADCC/ADCP [74]. This evidence concerns the gene FCGR2A and neoplasm.